In this edition, we feature Ofer Shay, CEO of DATAR Medical Innovations, a pioneering medical device company transforming postoperative recovery experiences with its revolutionary PainGuard™ technology.
Founded in March 2016, DATAR is on a mission to enhance patient care by improving and shortening postoperative recovery through cutting-edge technology. The company’s flagship product, the PainGuard™ infusion pump, is setting a new benchmark in continuous regional anesthesia administration. Clinical trials have demonstrated remarkable outcomes, including over 70% reduction in opioid consumption, more than 35% reduction in anesthetic drug usage, and significantly lower pain scores.
DATAR's story is one of persistence, innovation, and a relentless pursuit of excellence. Read on to discover how Ofer Shay and DATAR Medical Innovations are redefining postoperative care and pain management.
Tell us about your company.
Ofer Shay: DATAR stands at the forefront of postoperative pain management in both outpatient and inpatient settings, propelled by its groundbreaking PainGuard™ pumping technology. The PainGuard™ infusion pump establishes a new standard for continuous regional anesthesia administration, with clinical trials demonstrating a remarkable over 70% reduction in opioid consumption and over 35% in anesthetic drug consumption, alongside significantly lower pain scores.
Our mission is to improve and enhance postoperative recovery experiences. With a commitment to cutting-edge technology and a dedication to excellence, DATAR aspires to achieve global leadership in continuous pain management and postoperative care.
What made you become an entrepreneur?
Ofer Shay: I became an entrepreneur driven by a deep desire to develop innovative solutions to meaningful challenges. My passion lies in thinking beyond conventional boundaries and making a lasting impact as a leader in my field.
What is the most challenging part of running your own startup?
Ofer Shay: Fundraising is the most challenging part. While the technology and clinical benefits are evident, navigating investor conversations and securing funding for scaling has been a persistent challenge.
What is the biggest challenge you have faced when looking for funding?
Ofer Shay: Potential investors often have difficulty understanding the enormous business implications of what we are bringing to the market and its potential to disrupt this niche within medical devices.
What is the most rewarding aspect of entrepreneurship?
Ofer Shay: Realizing that our unique solution is a significant clinical improvement that will transform millions of lives. Seeing the tangible impact of our innovation on patient recovery and well-being keeps me inspired every day.
Watch the company snippet : https://www.youtube.com/watch?v=jzDRtdfNmSE&t=1s
Learn more about DATAR Medical Innovations on their website: https://datar-medical.com/.
Comentarios